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Abstract While the stress-response-associated importance of
the p53 tumor suppressor is well established, recent studies
have also linked p53 with several basic parameters in the normal
behavior of cells. Here, we present evidence that basal p53 ex-
pression in WI38 human embryonic lung ¢broblasts restricts
growth rate and mediates density-dependent inhibition of growth
and the associated G1 phase arrest of the cell cycle by a¡ecting
the density-dependent regulation of p16/INK4a. Additionally,
we show that prolonged culturing of hTert-immortalized WI38
cells leads to a loss of density-dependent growth inhibition that
correlates with p27/KIP deregulation as well as the previously
shown INK4a locus silencing, and to an onset of contact-in-
duced, p53-dependent cell death.
0 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
The p53 tumor suppressor protein has been shown to con-
stitute a major crossroads in the cellular response to a variety
of stress stimuli, including radiation, genotoxic damage, hyp-
oxia, etc. Under such stress conditions p53 is stabilized and
accumulates in the nucleus in the form of an active tetramer,
acting as a transcription factor in the regulation of a variety
of genes, chie£y pro-apoptotic and DNA-repair-oriented. p53
is lost or modi¢ed in most tumors, indicating its vital role in
limiting the growth of aberrant cells. The levels of p53 in the
cell are tightly controlled, primarily by a negative feedback
loop involving HdM2, which is transcriptionally induced by
p53 and targets p53 to ubiquitination and subsequent protea-
somal degradation (reviewed in[1,2]). Recent studies have
shown a functional role for p53 in its basal level, present in
non-stressed cells, particularly in cell motility and adhesion
[3,4].
Density-dependent inhibition of growth is a characteristic
of all types of normal somatic mammalian cells. In vitro, this
property manifests itself in a saturation curve of cell growth,
as the cells enter reversible growth arrest in a density-depen-
dent manner. Density-dependent inhibition of growth is fre-
quently absent in tumor cells and in tumor-derived cell lines
[5]. In WI38 ¢broblasts, in particular, this phenomenon has
been thoroughly characterized by Pignolo et al. and Owen et
al. [6,7].
Several cellular factors and pathways have been connected
to density-dependent inhibition of growth (reviewed in [8]),
among them p16/INK4a [9^11], p21/WAF [12,13], p27/KIP
[14^17], Gadd45K [18], S100C [19], VHL [20], and the cadher-
in^L-catenin signaling module [21,22]. Cadherin-mediated
cell^cell adhesion was recently shown to be regulated by
Bcl-2 [23], which is itself repressed by p53 in some cell types
[24]. L-Catenin is also known to interact with p53 via a neg-
ative feedback loop (reviewed in [2]), and p53 mutations have
been shown to result in abnormal L-catenin accumulation [25].
Besides the mutual connection to L-catenin, density-dependent
growth inhibition is a known factor in p53 regulation, sup-
pressing the p53 response to stress signals [26]. However, the
direct contribution of p53 to the density-dependent growth
inhibition response has remained largely unknown.
2. Materials and methods
2.1. Cell culture
Primary human embryonic lung ¢broblasts (WI38), amphotropic
and ecotropic Phoenix retrovirus-producing cells were purchased
from ATCC. WI38/hTert-immortalized cells from early and late pas-
sages were prepared and provided by M. Milyavsky. WI38 cells were
grown in minimal essential medium supplemented with 10% fetal calf
serum (FCS), 1 mM sodium pyruvate, 2 mM L-glutamine and anti-
biotics. Phoenix cells were grown in Dulbecco’s modi¢ed Eagle’s me-
dium supplemented with 10% FCS and 2 mM L-glutamine and anti-
biotics. All cells were maintained in a humidi¢ed incubator at 37‡C
and 5% CO2. Cells were split near con£uence by incubation with
trypsin and replated into a new 100 mm plate at a cell density of
1500 cells/cm2. Cumulative population doublings (CPDLs) were cal-
culated using the formula: CPDL= log (cell output/cell input)/log2.
Density-dependent growth inhibition was assessed by plating series
of 10000 cells/35 mm culture dish, periodical harvesting by trypsiniza-
tion and hemacytometer counting.
2.2. Retroviral constructs
Ecotropic receptor retroviral construct was kindly provided by Dr.
David Ginsberg (Weizmann Institute of Science), PLXSN-GSE56-
Neo was obtained by the subcloning of the GSE56 BamHI fragment
from pBabe-GSE56-puro [27,28] into PLXSN. pRetro-Super (Puro)
containing small interfering RNA (siRNA) against p53 was kindly
provided by Dr. Moshe Oren (Weizmann Institute of Science). pRe-
tro-Super (Puro) containing siRNA against p16 was kindly provided
by Dr. Reuven Agami (The Netherlands Cancer Institute).
2.3. Retroviral infection
Amphotropic and ecotropic Phoenix packaging cells were trans-
fected with 10 Wg DNA of the appropriate retroviral construct by a
standard calcium phosphate procedure. Culture supernatants were
collected 36^48 h post transfection and ¢ltered. WI38 cells were in-
fected with the ¢ltered viral supernatants in the presence of 4 Wg/ml
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polybrene (Sigma) for 12 h, after which the medium was changed.
Fresh viral suspensions were added after a 24 h interval for an addi-
tional 12 h. Infected cells were selected with 1 Wg/ml puromycin (5
days), 400 Wg/ml G418 (14 days) or 300 Wg/ml hygromycin (5 days).
2.4. Western blotting analysis
Cells were lysed in TLB bu¡er [Tris^HCl (50 mM), NaCl (100
mM), Triton X-100 (1%), Na-deoxycholate (0.5%), sodium dodecyl
sulfate (SDS, 0.1%)] supplemented with protease inhibitor cocktail
(Roche) and phosphatase inhibitor cocktail I and II (Sigma) for 30
min on ice. Extracts were analyzed for protein concentration by the
Bradford assay. 50 Wg of protein extract was dissolved in sample
bu¡er (140 mM Tris pH 6.8, 22.4% glycerol, 6% SDS, 10% L-mercap-
toethanol and 0.02% bromophenol blue), boiled and loaded on 10%
polyacrylamide gels containing SDS. Proteins were transferred to ni-
trocellulose membranes.
The following primary antibodies were used: mouse monoclonal
anti-p53 (1801, kindly provided by Dr. D. Lane), rabbit polyclonal
anti-p53 (home-made), mouse monoclonal anti-HDM2 (4B2, 2A9,
2A10; kindly provided by Dr. M. Oren), rabbit polyclonal anti-p21
(C-19; Santa Cruz), rabbit polyclonal anti-p16 (C-20; Santa Cruz),
mouse monoclonal anti-L-tubulin (Sigma), mouse monoclonal anti-
p27 (kindly provided by Dr. M. Oren), mouse monoclonal anti-vin-
culin (kindly provided by Dr. Benny Geiger), rabbit polyclonal anti-L-
catenin (kindly provided by Dr. A. Bershadsky).
The protein^antibody complexes were detected using horseradish
peroxidase-conjugated secondary antibodies and the SuperSignal en-
hanced chemiluminescence system (Pierce).
2.5. Cell cycle analysis
Cells were detached with trypsin, ¢xed in 70% ethanol, and treated
with 5 Wg/ml propidium iodide plus 0.1 mg/ml RNase A. Samples
were analyzed by £ow cytometry using a FACS Sorter machine (Bec-
ton Dickinson). At least 10 000 cells were analyzed per sample.
2.6. Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA was isolated using the RNAeasy kit (Qiagen). 2 mg was
reverse-transcribed using MMLV RT (Promega) and random hexamer
primers. Real-time quantitative RT-PCR for total p16/INK4A
mRNA was performed on an ABI 7000 (Applied Biosystems) machine
using SYBR Green PCR mastermix (Applied Biosystems). The values
for p16 were normalized to the GAPDH housekeeping control. Prim-
er sequences for SYBR Green real-time PCR of GAPDH were 5P-
ccaccaccctgttgctgta and 3P-accacagtccatgccatcac; p16/INK4a: 5P-gag-
cagcatggagccttcgg and 3P-catggttactgcctctggtg.
3. Results
3.1. Suppression of p53 in WI38 ¢broblasts by GSE56 increases
growth rate and delays the onset of replicative senescence
We chose to suppress p53 in WI38 human embryonic lung
¢broblasts by means of a dominant-negative peptide, GSE56,
described in [27,28]. Brie£y, the peptide competitively binds
the oligomerization domain of p53, thus preventing the for-
mation of transcriptionally active p53 tetramers while stabiliz-
ing a large amount of inactive p53 (probably due to a lack of
HdM2 up-regulation by p53, and perhaps also by avoiding
nuclear export, as may be inferred from the supplementary
¢gure). GSE56 was subcloned into a retroviral vector,
PLXSN, with which the cells were infected. Expression of
GSE56 and functional suppression of p53 in the infected cells
were veri¢ed by Western blot of p53, GSE56 and two well-
known transcriptional targets of p53, HdM2 and p21/WAF
(Fig. 1). Introduction of GSE56 into primary WI38 ¢broblasts
prolonged the replicative life span in these cells (Fig. 2b),
while in hTert-immortalized WI38 cells GSE56 enhanced the
rate of growth (Fig. 2a).
3.2. Suppression of p53 in WI38 ¢broblasts reduces
density-dependent inhibition of growth by abolishing
G1 phase cell cycle arrest
To assess the e¡ects of p53 suppression on density-depen-
dent inhibition of growth, hTert-immortalized WI38 ¢bro-
blasts with and without GSE56 expression, and primary
WI38 ¢broblasts with and without anti-p53 siRNA, were
seeded in culture dishes and allowed to grow beyond con£u-
ence, with periodical counting. As seen in Fig. 2c,d, GSE56-
expressing and p53RNAi-expressing cells, in addition to hav-
ing a higher growth rate in subcon£uent culture, achieved a
signi¢cantly higher ¢nal density in con£uent culture. Thus,
suppression of p53 by both GSE56 and p53RNAi results in
a reduced density-dependent growth inhibition response.
To assess whether this change is mirrored by the cell cycle
distribution of the cells, FACS cell cycle analysis was per-
formed on dense cultures of hTert-immortalized WI38 cells
with and without GSE56 expression. While control cells in
dense culture showed an almost uniform G1 phase arrest
(91% of cells were in G1, 4% in S and 5% in G2/M),
GSE56-expressing cells show a cell cycle distribution similar
to that of a proliferating culture, even after con£uence (dense
GSE56-expressing cells : 75% G1, 5% S, 20% G2/M; sparse
control cells : 57% G1, 13% S, 30% G2/M; Fig. 3). Similar
di¡erences were observed between dense cultures of primary
WI38 cells with and without GSE56 (data not shown). Thus,
the suppression of density-dependent growth inhibition by
inactivation of p53 is characterized by an abolition of G1
phase arrest in dense culture.
3.3. Suppression of p53 in late-passage, INK4a-locus-de¢cient
immortalized WI38 ¢broblasts by GSE56 overcomes
contact-induced cell death
The cyclin-dependent kinase inhibitor, p16/INK4a, has
been shown to mediate density-dependent inhibition of
growth and to undergo signi¢cant up-regulation in dense cul-
ture [10]. To assess whether the observed e¡ects of GSE56 on
density-dependent growth inhibition correlate with changes in
the status of the INK4a locus, the growth of late-passage
immortalized WI38 ¢broblasts with or without GSE56 expres-
sion was followed beyond con£uence (Fig. 2e). These cells
were characterized [29] as having undergone a silencing of
the INK4a locus by means of promoter region methylation,
associated with an increased growth rate and loss of contact
inhibition. While all late-passage cells reached markedly high-
Fig. 1. GSE56 functionally suppresses p53 while stabilizing inactive
p53 monomers. hTert-immortalized WI38 ¢broblasts were infected
with pLXSNeo retroviral plasmid containing GSE56 or the control
vector. DNA damage was induced by treatment with 1 Wg/ml cis-
platin for periods of 24 and 48 h, and Western blot analysis was
used to probe for GSE56, p53 and two well-known transcriptional
targets of p53, p21/WAF and HdM-2. L-Tubulin was used as load-
ing control. N/T: non-treated.
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er densities than early-passage immortalized cells described
above (in agreement with [29]), late-passage cells without
GSE56 showed the peculiar property of undergoing massive
cell death after reaching con£uence, while some cells in the
same culture continued proliferating. As no such phenomenon
was observed before the culture reached con£uence (data not
shown), it seems likely that the observed cell death was cell-
contact-induced. This assumption is also supported by the
predominantly perpendicular orientation of the surviving cells
that suggests a selective advantage for minimizing cell^cell
contacts in this culture, as opposed to all other con£uent
cultures examined, in which most cells had a locally parallel
orientation that allows for a better ¢lling of the available
space (Fig. 4). In contrast, GSE56-expressing cells of the
same passage after immortalization showed no density-in-
duced death, while maintaining a similar and high growth
rate and high ¢nal density. Thus, p53 mediates contact-in-
duced cell death in late-passage, pre-malignant, INK4a-de¢-
cient WI38 ¢broblasts. Notably, this function cannot be de-
scribed as a stress response in a traditional sense, as the cells
were maintained in normal culture conditions, at which no
up-regulation of p53 was noticeable (Fig. 7).
Fig. 2. Suppression of p53 in WI38 ¢broblasts enhances growth rate, postpones replicative senescence, reduces contact inhibition of growth and
prevents contact-induced cell death. a: Cumulative growth of hTert-immortalized WI38 ¢broblasts with and without GSE56 expression over a
period of V140 days. b: Cumulative growth of primary WI38 ¢broblasts with and without GSE56 expression over a period of V30 days. In
panels a and b cells were cultured in 100 mm dishes, detached prior to con£uence by trypsin, counted with a hemocytometer and re-seeded to
an initial density of 105 cells/plate. c: Contact inhibition of growth in early-passage (Vp.30) hTert-immortalized WI38 ¢broblasts with and
without GSE56 expression. d: Contact inhibition of growth in primary WI38 ¢broblasts (Vp.18) with and without p53-inhibitory RNA expres-
sion. e: Contact inhibition of growth and contact-induced cell death in late-passage (Vp.90) hTert-immortalized WI38 ¢broblasts with and
without GSE56 expression. In panels c^e cells were seeded to an initial density of 104 cells/plate in 35 mm dishes, periodically detached by tryp-
sin and counted with a hemocytometer. The data was averaged from four to six samples per time point. Cell density is in units of 104 cells/
cm2. PDL: population doublings. Error bars: S.D.
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3.4. The reduction of density-dependent inhibition of growth
in cells with suppressed p53 correlates with a smaller
up-regulation of p16/INK4a by cell density than in
control cells
p16/INK4a is an established mediator and marker of den-
sity-dependent growth inhibition [10]. To assess whether the
diminished density-dependent growth inhibition response in
cells with suppressed p53 activity correlates with a change in
the regulation of p16 in these cells, p16 protein levels were
determined by Western blot in WI38 ¢broblasts from sparse
and dense cultures. The analysis was performed on the follow-
ing cell lines: primary WI38 (p.19), WI38 expressing p53i
(p.19), hTert-immortalized WI38 (p.30^40 and p.90+),
hTert-immortalized WI38 expressing GSE56 (p.30^40 and
p.90+). As shown in Figs. 5 and 6, suppression of p53 activity
by both mechanisms (GSE56 and p53-inhibitory RNA) re-
sulted in a weaker up-regulation of p16 by culture density
than in the appropriate control cells, and in some cases, in
no up-regulation at all (Fig. 5). This result was obtained in
three independent experiments.
3.5. The e¡ect of p53 suppression on the regulation of p16 by
culture density is not transcriptional
p16/INK4a is not an established transcriptional target of
p53, neither was it present in a microarray analysis results
list of genes whose expression was signi¢cantly altered in
GSE56-expressing cells (data not shown). To check whether
the diminished density-dependent up-regulation of p16 in cells
with suppressed p53 activity is mirrored at the mRNA level,
cDNA was obtained from dense cultures of the di¡erent WI38
Fig. 3. Cell cycle analysis of a sparse culture of WI38-hTert-Neo (a) and dense cultures of WI38-hTert-Neo (b) and WI38-hTert-GSE56 (c).
Cells were cultured in 100 mm plates until 40% con£uence (a) or until 7 days after con£uence (b,c), FACS analysis was performed as described
in Section 2. Results shown are representative from three samples per category.
Fig. 4. Spatial organization of di¡erent WI38 strains in con£uent culture is indicative of defects in cell^cell contact signaling pathways. hTert-
immortalized WI38 ¢broblasts of early (p.30^p.40, top) and late (p.90^p.95, bottom) passages were infected with GSE56 (right) or the control
vector (left), grown to con£uence in 10 cm plates, ¢xed and stained with crystal violet and photographed at U200 magni¢cation.
FEBS 28053 3-2-04
A. Meerson et al./FEBS Letters 559 (2004) 152^158 155
cell lines described, and real-time quantitative PCR was per-
formed. As seen in Fig. 8, both p53-inhibitory RNA and
GSE56 expression actually caused an increase in p16
mRNA expression in both sparse and dense cultures, in con-
trast with the Western blot results. Furthermore, cells with
suppressed p53 exhibited a density-dependent up-regulation
of p16 mRNA similar to control cells. Thus, basal expression
of p53 is necessary for a non-transcriptional regulatory path-
way acting on p16/INK4a and mediating density-dependent
inhibition of growth.
3.6. E¡ect of prolonged culturing, but not of p53 suppression,
on density-dependent growth inhibition correlates with
inability to up-regulate p27
To assess whether the observed e¡ects of GSE56 on den-
sity-dependent growth inhibition correlate with changes in the
status of p27, an established marker for density-dependent
growth inhibition [14,16,17], the levels of p27 protein in sparse
and dense cells with and without GSE56 expression were
probed by Western blotting analysis. As seen in Fig. 5, ex-
pression of GSE56 did not result in a decrease of the expres-
sion levels of p27, or in a lack of its up-regulation in dense
culture. However, as seen in Fig. 7, in late-passage, INK4a-
de¢cient cells, p27 failed to accumulate as a function of cul-
ture density, again regardless of p53 status.
4. Discussion
While density-dependent inhibition of growth is a phenom-
enon of considerable complexity, it is among the easiest to
measure and observe in vitro, pointing on the cells’ interaction
with their immediate environment, their growth control sta-
tus, and sometimes indicative of their tumorigenic potential.
The contributions of particular pathways and factors to den-
sity-dependent growth arrest are only now being elucidated.
Here, we have demonstrated that basal expression of p53 in
non-stressed WI38 ¢broblasts is crucial for keeping cell pro-
liferation in check, both by restricting cellular growth rate and
by establishing a density-induced growth arrest. It is apparent
that at least two distinct pathways mediate these e¡ects down-
stream of p53. On the one hand, expression of the p21/WAF/
CIP1 cyclin-dependent kinase inhibitor, a known transcrip-
tional target of p53, declines dramatically in the absence of
the basal expression of p53, presumably a¡ecting cell cycle
progression and growth rate. On the other hand, p16/
INK4a, another cyclin-dependent kinase inhibitor, fails to ac-
cumulate in dense cultures, in correlation with a reduced den-
sity-dependent growth inhibition response (which it was
shown to mediate by [10]) and a lack of G1 arrest in these
cultures (which is also its known role, reviewed in [30]). Thus,
the observed changes in the regulation of p16 appear to be
highly relevant to the observed phenotypic e¡ects, following
p53 suppression. However, it is impossible to exclude the in-
volvement of additional pathways in the mediation of density-
dependent growth inhibition by p53.
p16/INK4a is not a known transcriptional target of p53,
and our results indicate that the induction of p16 mRNA
upon density-dependent growth inhibition is not p53-depen-
dent. However, we have shown that the p16 protein failed to
accumulate in dense WI38 cells with suppressed p53 to an
extent similar to that observed in control cells.
Assuming (from the suppression mechanism of GSE56) that
transcriptional activity of p53 is necessary for its contribution
to the density-dependent growth inhibition response, it is nat-
ural to expect that the involvement of p53 in density-depen-
dent inhibition of growth is achieved through an additional
signaling module, that is transcriptionally activated by p53
Fig. 5. Expression of several known contact inhibition markers
(p27/KIP, p21/WAF, p16/INK4a, L-catenin) in sparse and dense
cultures of early-passage (p.30^p.40) hTert-immortalized WI38 ¢bro-
blasts expressing GSE56 (two right lanes) or the control vector (two
left lanes). L-Tubulin was used as loading control.
Fig. 6. Expression of p16/INK4a in dense cultures of primary WI38
¢broblasts with and without p53-inhibitory RNA expression (two
left lanes) and early-passage hTert-immortalized WI38 ¢broblasts
expressing GSE56, with p16-inhibitory RNA or the control vector
(two right lanes). L-Tubulin was used as loading control. Levels of
p53 expression are shown for the two left lanes only.
Fig. 7. Expression of several known contact inhibition markers
(p27/KIP, p21/WAF, p16/INK4a) in sparse and dense cultures of
late-passage (p.90^95) hTert-immortalized WI38 ¢broblasts express-
ing GSE56 (two right lanes) or the control vector (two left lanes).
A positive control for p16 was used on the same membrane (not
shown). Vinculin was used as loading control.
FEBS 28053 3-2-04
A. Meerson et al./FEBS Letters 559 (2004) 152^158156
and modulates the levels of p16 in a non-transcriptional mech-
anism, possibly by a¡ecting the stability of the protein itself.
Additionally, we have shown that the regulation of p27/
KIP, another known mediator of density-dependent growth
arrest, is not a¡ected by the p53 status, while following pro-
longed culturing of immortalized cells its density-dependent
regulation is disrupted, in correlation with higher cell growth
rate and ¢nal culture density (also described in [29]). Pro-
longed culturing also causes the unique phenomenon of con-
tact-induced cell death, which can be abolished by p53 inacti-
vation and is, therefore, p53-dependent, in compliance with
the traditional role of p53 as a pro-apoptotic tumor suppres-
sor. Notably, this cell-death-promoting activity of p53 in late-
passage immortalized WI38 cells was also mediated by basal
amounts of p53, as no signi¢cant up-regulation of p53 was
observed in these cells.
These ¢ndings, combined with the comparison of the quan-
titative e¡ects of prolonged culturing and of p53 suppression
on density-dependent growth inhibition, suggest that the de-
regulation of density-dependent growth inhibition in these two
cases is achieved by di¡erentially acting on two distinct and
complementary pathways that mediate density-dependent in-
hibition of growth. In agreement with this conclusion, the
described e¡ects appear to be additive: late-passage immor-
talized WI38 cells with an additional inactivation of p53 ex-
hibit the highest ¢nal density in culture.
Acknowledgements: The authors would like to express their gratitude
to Dr. Alexander Bershadsky (MCB, Weizmann Institute of Science)
for sharing his formidable experience in cellular biology, Dr. Reuven
Agami (The Netherlands Cancer Institute) for kindly providing the
pSUPER technology, Dr. Andrei Gudkov (the Lerner Institute) for
kindly providing the GSE56 expression vector, and Dr. Matthew
Meyerson (Harvard Medical School) for an exceptionally well-timed
idea for an experiment.
References
[1] Oren, M. (1999) J. Biol. Chem. 274, 36031^36034.
[2] Oren, M. et al. (2002) Ann. NY Acad. Sci. 973, 374^383.
[3] Alexandrova, A., Ivanov, A., Chumakov, P., Kopnin, B. and
Vasiliev, J. (2000) Oncogene 19, 5826^5830.
[4] Sablina, A.A., Chumakov, P.M. and Kopnin, B.P. (2003) J. Biol.
Chem. (in press).
[5] Paul, D., Henahan, M. and Walter, S. (1974) J. Natl. Cancer
Inst. 53, 1499^1503.
[6] Pignolo, R.J., Rotenberg, M.O. and Cristofalo, V.J. (1994) In
Vitro Cell Dev. Biol. Anim. 30A, 471^476.
[7] Owen, T.A., Carter, R., Whitman, M.M., Soprano, D.R. and
Soprano, K.J. (1990) J. Cell Physiol. 142, 137^148.
[8] Nelson, P.J. and Daniel, T.O. (2002) Kidney Int. 61 (Suppl. 1),
99^105.
[9] Higashi, H., Suzuki-Takahashi, I., Yoshida, E., Nishimura, S.
and Kitagawa, M. (1997) Biochem. Biophys. Res. Commun.
231, 743^750.
[10] Wieser, R.J., Faust, D., Dietrich, C. and Oesch, F. (1999) Onco-
gene 18, 277^281.
[11] Yanagisawa, K., Kosaka, A., Iwahana, H., Nakanishi, M. and
Tominaga, S. (1999) J. Biochem. (Tokyo) 125, 36^40.
[12] Huang, Z.Y., Wu, Y., Hedrick, N. and Gutmann, D.H. (2003)
Mol. Cell. Biol. 23, 566^578.
[13] Ritt, M.G., Mayor, J., Wojcieszyn, J., Smith, R., Barton, C.L.
and Modiano, J.F. (2000) Cancer Lett. 158, 73^84.
[14] Deleu, L., Fuks, F., Spitkovsky, D., Horlein, R., Faisst, S. and
Rommelaere, J. (1998) Mol. Cell. Biol. 18, 409^419.
[15] Dietrich, C., Wallenfang, K., Oesch, F. and Wieser, R. (1997)
Oncogene 15, 2743^2747.
[16] Fuse, T. et al. (2000) J. Neurochem. 74, 1393^1399.
[17] Levenberg, S., Yarden, A., Kam, Z. and Geiger, B. (1999) On-
cogene 18, 869^876.
[18] Zhang, X., Ma, L., Enkemann, S.A. and Pledger, W.J. (2003)
Oncogene 22, 4166^4174.
Fig. 8. p16/INK4a mRNA expression levels in di¡erent WI38-derived cell types, normalized by GAPDH levels. The RT-PCR procedure is de-
scribed in Section 2. Error bars: S.D. from duplicates.
FEBS 28053 3-2-04
A. Meerson et al./FEBS Letters 559 (2004) 152^158 157
[19] Sakaguchi, M., Miyazaki, M., Inoue, Y., Tsuji, T., Kouchi, H.,
Tanaka, T., Yamada, H. and Namba, M. (2000) J. Cell Biol. 149,
1193^1206.
[20] Baba, M. et al. (2001) Oncogene 20, 2727^2736.
[21] Dietrich, C., Scherwat, J., Faust, D. and Oesch, F. (2002) Bio-
chem. Biophys. Res. Commun. 292, 195^199.
[22] Stockinger, A., Eger, A., Wolf, J., Beug, H. and Foisner, R.
(2001) J. Cell Biol. 154, 1185^1196.
[23] Li, L., Backer, J., Wong, A.S., Schwanke, E.L., Stewart, B.G.
and Pasdar, M. (2003) J. Cell Sci. (in press).
[24] Wu, Y., Mehew, J.W., Heckman, C.A., Arcinas, M. and Boxer,
L.M. (2001) Oncogene 20, 240^251.
[25] Cagatay, T. and Ozturk, M. (2002) Oncogene 21, 7971^7980.
[26] De⁄e, A., Hao, M., Montes de Oca Luna, R., Hulboy, D.L. and
Lozano, G. (1995) Mol. Cell. Biol. 15, 3926^3933.
[27] Ossovskaya, V.S. et al. (1996) Proc. Natl. Acad. Sci. USA 93,
10309^10314.
[28] Mittelman, J.M. and Gudkov, A.V. (1999) Somat. Cell Mol. Ge-
net. 25, 115^128.
[29] Milyavsky, M. et al. (2003) Cancer Res. 63, 7147^7157.
[30] Rocco, J.W. and Sidransky, D. (2001) Exp. Cell Res. 264, 42^55.
FEBS 28053 3-2-04
A. Meerson et al./FEBS Letters 559 (2004) 152^158158
